[go: up one dir, main page]

NL189092C - Hybride menselijke leukocytinterferons, dubbelstrengs dna dat hiervoor codeert, expressievector, transformant micro-organisme, werkwijzen ter bereiding daarvan en farmaceutisch preparaat. - Google Patents

Hybride menselijke leukocytinterferons, dubbelstrengs dna dat hiervoor codeert, expressievector, transformant micro-organisme, werkwijzen ter bereiding daarvan en farmaceutisch preparaat.

Info

Publication number
NL189092C
NL189092C NLAANVRAGE8105078,A NL8105078A NL189092C NL 189092 C NL189092 C NL 189092C NL 8105078 A NL8105078 A NL 8105078A NL 189092 C NL189092 C NL 189092C
Authority
NL
Netherlands
Prior art keywords
interferons
preparation
leukocytin
transformant
organism
Prior art date
Application number
NLAANVRAGE8105078,A
Other languages
English (en)
Dutch (nl)
Other versions
NL8105078A (nl
NL189092B (nl
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/237,388 external-priority patent/US4414150A/en
Priority claimed from US06/305,657 external-priority patent/US4456748A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NL8105078A publication Critical patent/NL8105078A/nl
Publication of NL189092B publication Critical patent/NL189092B/xx
Application granted granted Critical
Publication of NL189092C publication Critical patent/NL189092C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NLAANVRAGE8105078,A 1980-11-10 1981-11-10 Hybride menselijke leukocytinterferons, dubbelstrengs dna dat hiervoor codeert, expressievector, transformant micro-organisme, werkwijzen ter bereiding daarvan en farmaceutisch preparaat. NL189092C (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US20557980A 1980-11-10 1980-11-10
US20557980 1980-11-10
US23738881 1981-02-23
US06/237,388 US4414150A (en) 1980-11-10 1981-02-23 Hybrid human leukocyte interferons
US06/305,657 US4456748A (en) 1981-02-23 1981-09-25 Hybrid human leukocyte interferons
US30565781 1981-09-25

Publications (3)

Publication Number Publication Date
NL8105078A NL8105078A (nl) 1982-06-01
NL189092B NL189092B (nl) 1992-08-03
NL189092C true NL189092C (nl) 1993-01-04

Family

ID=27394813

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8105078,A NL189092C (nl) 1980-11-10 1981-11-10 Hybride menselijke leukocytinterferons, dubbelstrengs dna dat hiervoor codeert, expressievector, transformant micro-organisme, werkwijzen ter bereiding daarvan en farmaceutisch preparaat.

Country Status (34)

Country Link
EP (1) EP0051873B1 (fr)
JP (1) JP2642291B2 (fr)
KR (1) KR920007439B1 (fr)
AT (1) ATE46718T1 (fr)
AU (1) AU555293B2 (fr)
BR (1) BR8107293A (fr)
CA (2) CA1212915A (fr)
CH (2) CH663032A5 (fr)
DE (2) DE3177106D1 (fr)
DK (1) DK173590B1 (fr)
DO (1) DOP1981004064A (fr)
DZ (1) DZ350A1 (fr)
ES (2) ES506955A0 (fr)
FI (1) FI79550C (fr)
FR (1) FR2493867B1 (fr)
GB (1) GB2090258B (fr)
GR (1) GR81947B (fr)
HK (1) HK51685A (fr)
IE (1) IE51850B1 (fr)
IL (1) IL64243A (fr)
IT (1) IT1169276B (fr)
KE (1) KE3536A (fr)
LU (1) LU83745A1 (fr)
MC (1) MC1424A1 (fr)
MY (2) MY8700710A (fr)
NL (1) NL189092C (fr)
NO (1) NO165201C (fr)
NZ (1) NZ198906A (fr)
PH (1) PH18565A (fr)
PL (1) PL233748A1 (fr)
PT (1) PT73955B (fr)
SE (1) SE460539B (fr)
YU (1) YU46597B (fr)
ZW (1) ZW26981A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657141A5 (de) * 1980-07-01 1986-08-15 Hoffmann La Roche Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen.
JPS58501543A (ja) * 1981-08-14 1983-09-16 エイ／エス　アルフレツド　ベンツオン ヒトインタ−フエロン蛋白とヒトインタ−フエロン蛋白に対する抗体に関する改良
EP0072541A3 (fr) * 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Interferons de leucocytes humains, procédé pour leur production microbiologique, intermédiaires et compositions les contenant
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
EP0098876A1 (fr) * 1982-01-19 1984-01-25 Cetus Corporation Interferons hybrides de classes multiples
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1252046A (fr) * 1982-11-04 1989-04-04 Martin J. Cline Methodes de depistage du cancer
WO1984003300A1 (fr) * 1983-02-24 1984-08-30 Inst Organicheskogo Sinteza Ak Interferon n humain leucocytaire et son procede d'obtention dans des cellules bacteriennes
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
US4892743A (en) * 1983-12-21 1990-01-09 Schering Corporation Novel hybrid interferon species
EP0146903A3 (fr) * 1983-12-19 1987-07-22 Schering Corporation Production d'un vecteur qui encode un interféron hybride
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0173935A1 (fr) * 1984-08-31 1986-03-12 University Patents, Inc. Interférons humains d'hybrides de lymphoblastoides-leucocytes
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
EP0194006B1 (fr) * 1985-02-01 1992-04-29 Imperial Chemical Industries Plc Polypeptides analogues d'interféron, procédé pour les préparer et compositions pharmaceutiques les contenant
US4885166A (en) * 1985-06-11 1989-12-05 Ciba-Geigy Corporation Hybrid interferons
WO1987002037A1 (fr) * 1985-09-26 1987-04-09 Genetics Institute, Inc. Proteines tensio-actives pulmonaires
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
EP0490233A1 (fr) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Anticorps monoclonaux contre les interférons hybrides Bgl III, leur application et leur procédé de préparation
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
EP0331635A3 (fr) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Préparation pour le traitement du cancer de la vessie
US5372808A (en) † 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
GB2273931A (en) * 1992-09-28 1994-07-06 Unilever Plc Mutant polypeptides
AU701106B2 (en) 1995-06-07 1999-01-21 Promega Biosciences, Inc. Novel carbamate-based cationic lipids
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
WO2005113592A2 (fr) 2004-05-19 2005-12-01 Maxygen, Inc. Polypeptides et conjugues interferon-alpha
CN101501068A (zh) 2005-05-18 2009-08-05 马克西根公司 改进的α-干扰素多肽

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1346A (en) * 1980-01-08 1987-01-16 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides

Also Published As

Publication number Publication date
IT1169276B (it) 1987-05-27
EP0051873B1 (fr) 1989-09-27
GB2090258A (en) 1982-07-07
LU83745A1 (de) 1983-09-01
HK51685A (en) 1985-07-12
NO813785L (no) 1982-05-11
CH660743A5 (de) 1987-06-15
IL64243A0 (en) 1982-02-28
NL8105078A (nl) 1982-06-01
DE3177106D1 (en) 1989-11-02
ES8304200A1 (es) 1983-03-01
IE812622L (en) 1982-05-10
JPH07308191A (ja) 1995-11-28
ES8302778A1 (es) 1983-02-01
AU555293B2 (en) 1986-09-18
CA1277616C (fr) 1990-12-11
IL64243A (en) 1985-11-29
EP0051873A2 (fr) 1982-05-19
YU265681A (en) 1984-08-31
KR830007825A (ko) 1983-11-07
MC1424A1 (fr) 1982-10-18
GB2090258B (en) 1984-05-02
DK494681A (da) 1982-05-11
FR2493867A1 (fr) 1982-05-14
NZ198906A (en) 1985-12-13
KE3536A (en) 1985-06-07
ES506955A0 (es) 1983-02-01
NO165201C (no) 1991-01-16
ATE46718T1 (de) 1989-10-15
MY8700710A (en) 1987-12-31
SE8106641L (sv) 1982-06-24
DZ350A1 (fr) 2004-09-13
CH663032A5 (de) 1987-11-13
IT8124967A0 (it) 1981-11-10
YU46597B (sh) 1994-01-20
PH18565A (en) 1985-08-09
NO165201B (no) 1990-10-01
BR8107293A (pt) 1982-08-03
MY8800066A (en) 1988-12-31
PL233748A1 (en) 1983-07-18
CA1212915A (fr) 1986-10-21
FI79550C (fi) 1990-01-10
DK173590B1 (da) 2001-04-02
PT73955A (en) 1981-12-01
KR920007439B1 (ko) 1992-09-01
SE460539B (sv) 1989-10-23
JP2642291B2 (ja) 1997-08-20
ZW26981A1 (en) 1982-06-02
ES512354A0 (es) 1983-03-01
FI813539L (fi) 1982-05-11
NL189092B (nl) 1992-08-03
DOP1981004064A (es) 1988-03-16
EP0051873A3 (en) 1982-09-22
FI79550B (fi) 1989-09-29
IE51850B1 (en) 1987-04-15
PT73955B (en) 1983-11-23
DE3144469A1 (de) 1982-09-02
FR2493867B1 (fr) 1986-06-27
GR81947B (fr) 1984-12-12
AU7730481A (en) 1982-05-20

Similar Documents

Publication Publication Date Title
NL189092C (nl) Hybride menselijke leukocytinterferons, dubbelstrengs dna dat hiervoor codeert, expressievector, transformant micro-organisme, werkwijzen ter bereiding daarvan en farmaceutisch preparaat.
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
IE811463L (en) Interferons
PT97316A (pt) Sequencias de dna,construcoes de dna e metodo para a sua aplicacao no tratamento de doencas celulares proliferativas
ATE69241T1 (de) Herstellung von polypeptiden mit humangammainterferon-aktivitaet.
DE3683267D1 (de) Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung.
NO177863C (no) Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer
EP0209568A4 (fr) Sequences d'adn, molecules d'adn recombinant et procedes de production de polypeptides similaires a la lipocortine humaine.
EP0072541A3 (fr) Interferons de leucocytes humains, procédé pour leur production microbiologique, intermédiaires et compositions les contenant

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 19970601